Xometry, Inc.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations ($31.1m) ($61.4m) ($79.0m) ($67.5m) ($50.4m) ($61.7m) ($30.8m)
Net loss ($31.0m) ($31.1m) ($61.4m) ($76.0m) ($67.5m) ($50.4m) ($61.7m)
Net Income (Loss) Attributable to Parent ($31.1m)
($61.4m) -97.46%
($76.0m) -23.86%
($67.5m) +11.25%
($50.4m) +25.30%
($61.7m) -22.50%
Net Income (Loss) Available to Common Stockholders, Basic ($39.9m)
($61.4m) -53.89%
($76.0m) -23.86%
($67.5m) +11.25%
($50.4m) +25.30%
($61.7m) -22.50%
Net Income (Loss) Attributable to Noncontrolling Interest $2k $16k $7k ($2k) ($5k)
Depreciation, Depletion and Amortization $1.8m $3.1m $3.6m $7.8m $10.7m $13.0m $18.8m $20.8m
Amortization of Debt Issuance Costs and Discounts $1.7m $1.9m $1.9m $2.1m
Amortization of Intangible Assets $833k $464k $3.4m $3.3m $3.3m $3.2m
Depreciation $1.8m $2.3m $3.1m $4.0m $7.0m $9.4m $15.2m $20.8m
Amortization of deferred costs on convertible notes $1.7m $1.9m $1.9m $2.1m
Depreciation Amortization Depletion $7.8m $10.7m $13.0m $18.8m $20.8m
Deferred Income Tax Expense (Benefit) $0 ($179k) ($653k) ($154k) ($46k) ($84k) ($73k)
Deferred tax benefit $0 $0 ($179k) ($653k) ($154k) ($46k) ($84k)
Share-based Payment Arrangement, Noncash Expense $1.0m $7.4m $19.2m $22.1m $29.3m $36.4m $40.8m
Share-based Payment Arrangement, Expense $1.0m $7.4m $19.2m $22.1m $29.3m $36.4m $40.8m
Stock-based compensation $544k $1.0m $7.4m $19.2m $22.1m $29.3m $36.4m $40.8m
Equity Method Investment, Other than Temporary Impairment $0 $0
Goodwill and Intangible Asset Impairment $1.6m
Goodwill, Impairment Loss $1.5m $3.6m
Impairment of Intangible Assets (Excluding Goodwill) $100k $0 $0 $0 $0
Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss ($1.9m)
Impairment of assets $1.6m $824k $397k $82k $49k
Asset Impairment Charge $8.2m $15.0m $4.5m $4.7m $3.6m
Income (Loss) from Equity Method Investments $41k $570k $446k $452k $404k
Other Nonoperating Income (Expense) ($1.5m) ($757k) ($19.7m)
Earnings (Loss)es From Equity Investments $130k ($46k) ($42k) ($90k) ($101k)
Nonoperating Income (Expense) ($1.9m) ($2.7m) ($1.9m) $5.8m $5.7m ($15.6m)
Changes in operating assets and liabilities:
Change In Working Capital ($26.5m) ($13.6m) ($15.5m) ($13.6m) ($13.6m)
Increase (Decrease) in Accounts Receivable $2.1m $11.1m $16.9m $20.6m $5.7m $21.8m ($41.6m)
Accounts receivable, net ($5.5m) ($2.1m) ($11.1m) ($16.9m) ($20.6m) ($5.7m) ($21.8m) ($41.6m)
Change In Receivables ($17.0m) ($20.6m) ($5.7m) ($21.8m) ($41.6m)
Changes In Account Receivables ($17.0m) ($20.6m) ($5.7m) ($21.8m) ($41.6m)
Increase (Decrease) in Inventories $956k ($293k) ($351k) $1.6m $1.3m ($135k) $684k
Inventory Write-down ($15k) $133k $223k $0
Inventory write-off ($141k) ($15k) $133k $223k $0 $0
Inventory ($555k) ($956k) $293k $351k ($1.6m) ($1.3m) $135k $684k
Increase (Decrease) in Accounts Payable ($2.4m) $5.2m ($215k) $6.7m $28.5m
Accounts payable and accrued cost of revenue ($215k)
$12.6m +5957.21%
($8.7m) -169.13%
$9.2m +205.21%
$28.5m +210.67%
Change In Payables And Accrued Expense $934k $13.9m ($7.5m) $15.9m $28.5m
Other accrued expenses $406k $1.6m $2.7m $7.4m
Change In Accrued Expense $406k $1.6m $2.7m $7.4m $11.0m
Other assets ($137k) ($469k) $317k ($7.0m) ($80k) $4.2m ($772k)
Other liabilities $0 $527k ($24k)
Change In Other Current Assets ($4.1m) ($80k) $4.2m ($772k) ($7.1m)
Change In Other Current Liabilities ($5.7m) ($5.5m) ($6.4m) ($6.9m) ($4.7m)
Net Cash Provided by (Used in) Operating Activities ($27.1m)
($22.0m) +18.71%
($68.6m) -210.99%
($62.6m) +8.74%
($29.9m) +52.25%
($15.4m) +48.51%
$6.1m +139.56%
$27.7m +355.90%
Cash flows from investing activities:
Gain (Loss) on Disposition of Property Plant Equipment $155k ($20k) ($47k) ($92k) ($3k) $0 ($101k)
Payments to Acquire Property, Plant, and Equipment ($2.7m) $4.2m $6.3m $13.7m $18.5m $18.1m $30.2m ($41.7m)
Marketable Securities, Unrealized Gain (Loss) ($2.0m)
Purchases of marketable securities ($267.5m) ($284.1m) ($11.6m) ($18.8m) ($8.5m)
Proceeds from sale of marketable securities $235.0m $58.9m $50.0m $16.5m $22.0m
Payments to Acquire Businesses, Net of Cash Acquired $174.6m $3.3m $0 $0
Net cash (used in) provided by investing activities ($2.4m) $6.7m ($212.7m) ($238.6m) $16.8m ($20.2m) ($16.6m)
Net Cash Provided by (Used in) Investing Activities $6.7m ($212.7m) ($238.6m) $16.8m ($20.2m) ($16.6m) ($327.5m)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt ($272k) ($16.4m)
Loss on debt extinguishment $272k $0 $16.4m
Issuance Of Debt $287.5m $0 $0 $250.0m $0
Long Term Debt Issuance $287.5m $0 $0 $250.0m $0
Net Issuance Payments Of Debt $287.5m $0 $0 $34.0m $0
Net Long Term Debt Issuance $287.5m $0 $0 $34.0m $0
Long Term Debt Payments ($2k) $0 $0 ($216.0m) $0
Repayment Of Debt ($2k) $0 $0 ($216.0m) $0
Donation of common stock $2.2m $2.3m $1.0m $1.7m $3.3m
Issuance Of Capital Stock $325.3m $0 $0
Repurchase Of Capital Stock $0 $0 $0 ($8.1m) $0
Common Stock Issuance $325.3m $0 $0 $0 ($8.1m)
Payments for Repurchase of Common Stock $8.1m
Common Stock Payments $0 $0 ($8.1m) $0
Cash Dividends Paid $0 $0 $0
Dividends Received CFI $0 $0 $90k $86k $20k
Preferred Stock Dividend Paid $0 $0 $0
Net Other Financing Charges ($10.2m) ($842k) ($465k) ($26.1m) ($1.1m)
Net Cash Provided by (Used in) Financing Activities $54.7m
$35.3m -35.56%
$307.8m +772.83%
$281.0m -8.71%
$1.1m -99.62%
$4.6m +334.77%
$2.9m -37.70%
$304.8m +10447.58%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $19.8m $26.4m ($20.6m) ($12.2m) ($31.2m) ($7.2m) $21.8m
Beginning Cash Position $86.3m $65.7m $53.4m $22.2m $16.8m
Cash and cash equivalents at beginning of the year $40.1m $59.9m $86.3m $65.7m $53.4m $22.2m $15.0m
Effect Of Exchange Rate Changes ($367k) ($234k) ($268k) $424k ($36k)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Income Tax Expense (Benefit) $36k ($353k) ($21k) $589k
Operating Lease, Expense $1.2m $1.7m $7.8m $15.1m $5.2m $5.2m
Additional Financial Items
Gain (Loss) on Termination of Lease $14k
General and Administrative Expense $12.0m $34.9m $58.0m $70.9m $65.0m $72.3m
Goodwill $833k $254.7m $258.0m $262.9m $262.7m $263.8m $3.6m
Operating Expenses $62.5m $115.8m $221.6m $251.8m $271.8m $314.3m
Proceeds from Stock Options Exercised $450k $518k $2.3m $3.7m $1.9m $5.1m $3.1m
Reduction in carrying amount of right-of-use asset $647k $1.0m $1.1m $7.2m $14.4m $4.5m $4.6m
Lease termination $0 $0 ($14k)
Revaluation of contingent consideration $817k $571k $137k $0
Income from unconsolidated joint venture ($41k) $130k ($46k) ($42k) ($90k)
Prepaid expenses ($2k) ($210k) ($4.0m) ($1.6m) $1.7m $599k ($2.3m)
Contract liabilities $636k $518k ($1.6m) $515k ($1.4m) $681k $2.2m
Lease liabilities ($653k) ($1.0m) ($845k) ($5.7m) ($5.5m) ($6.9m) ($6.9m)
Income taxes payable $743k ($312k) ($1.5m) ($710k)
Distributions in excess of earnings $0 $90k $86k
Proceeds from issuance of convertible notes $287.5m $0 $0 $250.0m
Costs incurred in connection with issuance of convertible notes ($9.3m) $0 $0 ($8.7m)
Payments for repurchase of convertible notes $0 $0 ($216.0m)
Purchase of capped calls $0 $0 ($17.5m)
Purchase of treasury stock $0 $0 ($8.1m)
Payment of contingent consideration ($932k) ($842k) ($465k) $0
Non-cash consideration in connection with business combination $2.7m $105.2m ($518k) $1.6m $625k $625k
Cash Flow From Continuing Financing Activities $281.0m $1.1m $4.6m $2.9m $304.8m
Cash Flow From Continuing Investing Activities ($238.6m) $16.8m ($20.2m) ($16.6m) ($327.5m)
Change In Account Payable ($215k) $12.6m ($8.7m) $9.2m $28.5m
Change In Other Working Capital $735k ($1.4m) $681k $2.2m $3.4m
Change In Payable $528k $12.3m ($10.2m) $8.4m $28.5m
Change In Prepaid Assets ($1.6m) $1.7m $599k ($2.3m) ($3.1m)
Change In Tax Payable $743k ($312k) ($1.5m) ($710k) ($598k)
Changes In Cash ($20.2m) ($12.0m) ($30.9m) ($7.7m) $5.0m
End Cash Position $65.7m $53.4m $22.2m $15.0m $21.8m
Financing Cash Flow $281.0m
$1.1m -99.62%
$4.6m +334.77%
$2.9m -37.70%
$304.8m +10447.58%
Free Cash Flow ($76.2m) ($48.4m) ($33.5m) ($24.1m) ($13.9m)
Gain Loss On Investment Securities $2.0m $1.9m
Gain Loss On Sale Of PPE $47k $92k $3k $0 $26k
Investing Cash Flow ($238.6m) $16.8m ($20.2m) ($16.6m) ($327.5m)
Net Business Purchase And Sale $0 ($3.3m) $0 $0 $0
Net PPE Purchase And Sale ($13.5m) ($18.3m) ($18.0m) ($30.2m) ($41.7m)
Net Preferred Stock Issuance $0 $0 $0
Operating Gains Losses $2.0m $46k ($39k) $16.3m ($101k)
Other Non Cash Items $6.4m $3.5m $3.7m $5.4m
Preferred Stock Payments $0 $0 $0
Proceeds From Stock Option Exercised $3.7m $1.9m $5.1m $3.1m $7.6m
Purchase Of Business $0 ($3.3m) $0 $0 $0
Purchase Of PPE ($13.7m) ($18.5m) ($18.1m) ($30.2m) ($41.7m)
Sale Of PPE $189k $223k $79k $0 $0
Cash paid for business combination, net of cash acquired ($1.4m) ($174.6m) ($3.3m) $0 $0
Net Investment Purchase And Sale ($225.2m) $38.4m ($2.3m) $13.5m ($285.9m)
Purchase Of Investment ($284.1m) ($11.6m) ($18.8m) ($8.5m) ($330.9m)
Sale Of Investment $58.9m $50.0m $16.5m $22.0m $45.0m
Net decrease in cash and cash equivalents $25.2m $19.8m $26.4m ($20.6m) ($12.2m) ($31.2m) ($7.2m)
Effect of foreign currency translation on cash and cash equivalents ($130k) ($61k) ($367k) ($234k) ($268k) $424k
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported ($20.6m) ($12.2m) ($31.2m) ($7.2m)
Interest Paid, Excluding Capitalized Interest, Operating Activities $1.1m $1.3m $907k $1.4m $2.9m $2.9m $3.6m
Income Taxes Paid, Net $1.0m